Secondary Outcomes
uveitis
REMISSION, UVEITIS
Abbreviations: BCVA, best corrected visual acuity; LogMAR, log of the minimum angle of resolution.Unless otherwise indicated, data are expressed as No. (%) of patients.COVID-19 vaccination schedule included 2 primary doses of inactivated vaccines (CoronaVac [Sinovac Biotech] and BBIBP-CorV [Sinopharm]) or 3 doses of a protein subunit vaccine (ZF2001 [Anhui Zhifei Longcom Biopharmaceutical Co, Ltd]).In the deferred vaccination group, 4 patients had complete remission of uveitis during the study period and should have been vaccinated according to the trial recommendation.Each patient may have had 2 or more reasons.These outcomes were assessed in the month 3 in-person evaluable population (n = 249) relative to the baseline condition.Analyzed by eye with the generalized estimating equation to account for baseline values and the correlation between eyes of the same patient. Visual acuity data are expressed as LogMAR scores, with higher values indicating poorer visual acuity.